Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands

Clin Vaccine Immunol. 2011 Mar;18(3):469-76. doi: 10.1128/CVI.00396-10. Epub 2011 Jan 5.

Abstract

To gain insight into the age at which children become infected with influenza viruses for the first time, we analyzed the seroprevalence of antibodies against influenza viruses in children 0 to 7 years of age in the Netherlands. Serum samples were collected during a cross-sectional population-based study in 2006 and 2007 and were tested for the presence of antibodies against influenza A/H1N1, A/H3N2, and B viruses representative of viruses present in previous influenza seasons using the hemagglutination inhibition assay. The seroprevalence of antibodies to influenza virus was higher in children 1 to 6 months of age than in children 7 to 12 months of age, which likely reflects the presence of maternally derived antibodies. The proportion of study subjects >1 year of age with detectable antibodies against influenza viruses gradually increased with age until they reached the age of 6 years, when they all had antibodies to at least one influenza A virus. These findings may have implications for the development of vaccination strategies aiming at the protection of young children against seasonal and/or pandemic influenza virus infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral / blood*
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Hemagglutination Inhibition Tests
  • Humans
  • Infant
  • Influenza A Virus, H1N1 Subtype / immunology*
  • Influenza A Virus, H3N2 Subtype / immunology*
  • Influenza B virus / immunology*
  • Influenza, Human / epidemiology*
  • Influenza, Human / immunology
  • Influenza, Human / virology
  • Netherlands / epidemiology
  • Seroepidemiologic Studies

Substances

  • Antibodies, Viral